52 related articles for article (PubMed ID: 12567071)
1. Quality-of-Life Outcomes for Excision and Reconstruction of Periocular Nonmelanoma Skin Cancer.
Kinde B; Idowu OO; Ashraf DC; Chen RM; Hirabayashi KE; Grob SR; Winn BJ; Kersten RC; Vagefi MR
Facial Plast Surg Aesthet Med; 2024; 26(3):303-309. PubMed ID: 34227877
[No Abstract] [Full Text] [Related]
2. Increased risk of nonmelanoma skin cancer in patients with alpha-1 antitrypsin deficiency: A nationwide cohort study.
Korsbæk NJ; Landt EM; Marott S; Nordestgaard BG; Vinding GR; Jemec GBE; Dahl M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38695670
[No Abstract] [Full Text] [Related]
3. Nonmelanoma Skin Cancer in COVID-19 Era: The Foggia Experience.
Lembo F; Cecchino LR; Parisi D; Portincasa A
J Cutan Aesthet Surg; 2022; 15(4):436-438. PubMed ID: 37035590
[No Abstract] [Full Text] [Related]
4. A systematic review of patient-reported outcome measures for advanced skin cancer patients.
Reinhardt ME; Sun T; Pan CX; Schmults CD; Lee EH; Waldman AB
Arch Dermatol Res; 2023 Aug; 315(6):1473-1480. PubMed ID: 36469125
[TBL] [Abstract][Full Text] [Related]
5. Burden of Itch in Patients with Basal Cell Carcinoma.
Chlebicka I; Stefaniak AA; Matusiak Ł; Szepietowski JC
Acta Derm Venereol; 2021 Jul; 101(7):adv00507. PubMed ID: 34230980
[TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas.
Sampogna F; Paradisi A; Iemboli ML; Fania L; Ricci F; Napolitano M; Abeni D
Acta Derm Venereol; 2021 Apr; 101(4):adv00439. PubMed ID: 33372685
[TBL] [Abstract][Full Text] [Related]
7. Physician-Centered Outcomes for Skin Cancer Treatment: A Single-Day Modified Delphi Process to Assess the Importance of Themes in Skin Cancer Management.
Rossi AM; Sobanko J; Lawrence N; Bordeaux J; Cartee T; Armbrecht ES; Behera A; Baum CL; Alam M; Maher IA
Dermatol Surg; 2019 Jul; 45(7):869-874. PubMed ID: 30807387
[TBL] [Abstract][Full Text] [Related]
8. Patient-Centered Outcomes for Skin Cancer Management: Utilization of a Patient Delphi Process to Identify Important Treatment Themes.
Cartee TV; Alam M; Armbrecht ES; Behera A; Lawrence N; Bordeaux JS; Baum CL; Rossi A; Maher IA
Dermatol Surg; 2019 Feb; 45(2):246-253. PubMed ID: 30726197
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of the Spanish Version of the "Skin Cancer Index".
de Troya-Martín M; Rivas-Ruiz F; Blázquez-Sánchez N; Fernández-Canedo I; Aguilar-Bernier M; Repiso-Jiménez JB; Toribio-Montero JC; Jones-Caballero M; Rhee J
J Skin Cancer; 2016; 2016():8180348. PubMed ID: 27800183
[No Abstract] [Full Text] [Related]
10. Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses.
Bretterklieber A; Painsi C; Avian A; Wutte N; Aberer E
BMC Res Notes; 2014 Sep; 7():594. PubMed ID: 25183055
[TBL] [Abstract][Full Text] [Related]
11. The nature and extent of body image concerns among surgically treated patients with head and neck cancer.
Fingeret MC; Yuan Y; Urbauer D; Weston J; Nipomnick S; Weber R
Psychooncology; 2012 Aug; 21(8):836-44. PubMed ID: 21706673
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
Weinstock MA; Lee KC; Chren MM; Marcolivio K;
J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
[TBL] [Abstract][Full Text] [Related]
13. Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization.
Victorson D; Barocas J; Song J; Cella D
Qual Life Res; 2008 Nov; 17(9):1137-46. PubMed ID: 18841493
[TBL] [Abstract][Full Text] [Related]
14. The skin cancer index: clinical responsiveness and predictors of quality of life.
Rhee JS; Matthews BA; Neuburg M; Logan BR; Burzynski M; Nattinger AB
Laryngoscope; 2007 Mar; 117(3):399-405. PubMed ID: 17334300
[TBL] [Abstract][Full Text] [Related]
15. Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer.
Rhee JS; Matthews BA; Neuburg M; Logan BR; Burzynski M; Nattinger AB
Arch Facial Plast Surg; 2006; 8(5):314-8. PubMed ID: 16982987
[TBL] [Abstract][Full Text] [Related]
16. Development of the facial skin care index: a health-related outcomes index for skin cancer patients.
Matthews BA; Rhee JS; Neuburg M; Burzynski ML; Nattinger AB
Dermatol Surg; 2006 Jul; 32(7):924-34; discussion 934. PubMed ID: 16875475
[TBL] [Abstract][Full Text] [Related]
17. Creation of a quality of life instrument for nonmelanoma skin cancer patients.
Rhee JS; Matthews BA; Neuburg M; Burzynski M; Nattinger AB
Laryngoscope; 2005 Jul; 115(7):1178-85. PubMed ID: 15995503
[TBL] [Abstract][Full Text] [Related]
18. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy.
Crevenna R; Zettinig G; Keilani M; Posch M; Schmidinger M; Pirich C; Nuhr M; Wolzt M; Quittan M; Fialka-Moser V; Dudczak R
Support Care Cancer; 2003 Sep; 11(9):597-603. PubMed ID: 12783288
[TBL] [Abstract][Full Text] [Related]
19. Quality of life assessment in nonmelanoma cervicofacial skin cancer.
Rhee JS; Loberiza FR; Matthews BA; Neuburg M; Smith TL; Burzynski M
Laryngoscope; 2003 Feb; 113(2):215-20. PubMed ID: 12567071
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
